800-331-6634

Latest News

One in four anti-VEGF therapy patients with DME lost to follow-up

Dr. Jason Hsu leads a study that looks into the loss of follow-up visits with patients suffering from non-proliferative diabetic retinopathy. The study has found that a quarter of patients do not return within a year of receiving an anti-VEGF injection. Read more about the study from Healio.  ... read more

Healthwatch - Carl D. Regillo, MD, FACS

Dr. Carl Regillo, Chief of Wills Eye Retina Service, explains the risk diabetes imposes on your vision if not treated or detected early. Watch the full clip here to learn more. ... read more

Read All